Skip to main content
    B

    Bio-Rad Laboratories Inc (BIO-B)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $367.05
    -22.93 (-5.88%)

    Market Cap: $10.49B

    Last updated: Nov 17, 2026 at 4:00 PM ET

    Bio-Rad Laboratories Inc (BIO-B) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Bio-Rad Laboratories (BIO-B) closed at $367.05 on Nov 17, 2026, 5.9% below its 52-week high of $389.98. Its price rose 16.7% over the past 12 months. The month-end price rose 132.8% over the 10 years through Oct 2026, a compound annual rate of 8.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $762.80 in Aug 2021 and its lowest $163.00 in Oct 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart BIO-B with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BIO-B.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 8.9%, and over 6 months it rose 37.3%. The month-end price rose 39.0% over the 3 years through Oct 2026, a compound annual rate of 11.6%.

    PeriodChange
    1 month+0.8%
    3 months+8.9%
    6 months+37.3%
    12 months+16.7%
    12 months, with dividends+16.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+39.0%+11.6%
    5 years-48.0%-12.3%
    10 years+132.8%+8.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 60.7%, and its weakest was 2022, when it fell 44.0%.

    YearCloseChange
    2026 through Oct 2026$379.50+22.1%
    2025$310.70-4.6%
    2024$325.60+1.5%
    2023$320.65-20.8%
    2022$404.66-44.0%
    2021$722.91+25.9%
    2020$574.15+55.3%
    2019$369.60+60.7%
    2018$230.00-3.5%
    2017$238.25+30.1%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 0.9% below its 50-day average of $370.54 and 16.4% above its 200-day average of $315.41.

    MeasureValuePrice vs
    Close (Nov 17, 2026)$367.05
    52-week high$389.98-5.9%
    52-week low$244.54+50.1%
    50-day average$370.54-0.9%
    200-day average$315.41+16.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 37.0%.

    MeasureValue
    1-year beta0.13
    Largest fall, 1 year-18.3%
    Largest fall, 3 years-37.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Bio-Rad Laboratories traded at 11.1x earnings at the end of 2025, against a 10-year median of 46.7x.

    BIO-B valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About BIO-B

    What is BIO-B's 1-year price change?

    Bio-Rad Laboratories's price rose 16.7% over the past 12 months. With dividends included, the 12-month total return was 16.7%.

    What is BIO-B's 5-year price change?

    Bio-Rad Laboratories's month-end price fell 48.0% over the 5 years through Oct 2026, a compound annual decline of 12.3%. These figures leave out dividends.

    What is BIO-B's 52-week high and low?

    Bio-Rad Laboratories's 52-week high is $389.98 and its 52-week low is $244.54. Its close of $367.05 on Nov 17, 2026 is 5.9% below the high.

    What is BIO-B's beta?

    Bio-Rad Laboratories's 1-year beta against the S&P 500 is 0.13, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 18.3%.

    Is the BIO-B chart free?

    Yes. Advanced Charting for BIO-B is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.